SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-044318
Filing Date
2024-10-30
Accepted
2024-10-30 16:09:59
Documents
15
Period of Report
2024-10-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cort-20241030.htm   iXBRL 8-K 26127
2 EX-99.1 exhibit991pressrelease10-3.htm EX-99.1 87328
  Complete submission text file 0001628280-24-044318.txt   282510

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20241030.xsd EX-101.SCH 2049
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20241030_def.xml EX-101.DEF 14911
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20241030_lab.xml EX-101.LAB 26379
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20241030_pre.xml EX-101.PRE 15557
17 EXTRACTED XBRL INSTANCE DOCUMENT cort-20241030_htm.xml XML 3650
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 241410386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)